A four gene signature predictive of recurrent prostate cancer.

Oncotarget · 2017 · PMC5356893 · PMID 27966447

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp= 1.38×10 -6actually significant

Only one patient in the cohort predicted not to recur (n = 8) experienced biochemical recurrence 126 weeks post-prostatectomy, a highly significant result (p= 1.38×10 -6 , log-rank test).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.